MedPath

IPSEN, OOO

🇫🇷France
Ownership
-
Established
1929-01-01
Employees
5.7K
Market Cap
$9.8B
Website
https://www.ipsen.com/

Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines

Phase 3
Completed
Conditions
Glabellar Lines
Interventions
Drug: Placebo
Biological: Botulinum toxin type A
First Posted Date
2015-07-10
Last Posted Date
2022-09-28
Lead Sponsor
Ipsen
Target Recruit Count
600
Registration Number
NCT02493946
Locations
🇫🇷

Clinique Iéna, Paris, France

🇫🇷

CHRU Hôpital, Besançon cedex, France

🇩🇪

Medical Skin Center, Düsseldorf, Germany

and more 20 locations

Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly

Phase 3
Completed
Conditions
Acromegaly
Interventions
First Posted Date
2015-07-09
Last Posted Date
2019-01-29
Lead Sponsor
Ipsen
Target Recruit Count
128
Registration Number
NCT02493517
Locations
🇨🇳

Peking Union Medical College Hospital, Beijing, China

🇨🇳

West China Hospital, Sichuan University, Chengdu, China

🇨🇳

Fujian Provincial Hospital, Fuzhou, China

and more 7 locations

Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice

Completed
Conditions
Upper Limb Spasticity
First Posted Date
2015-05-27
Last Posted Date
2019-08-05
Lead Sponsor
Ipsen
Target Recruit Count
1004
Registration Number
NCT02454803
Locations
🇺🇸

Vanderbilt University, Nashville, Tennessee, United States

🇦🇹

Gaitlal-Klinik Hermagor, Hermagor, Austria

🇵🇹

Hospital Egas Moniz, Lisboa, Portugal

and more 54 locations

Dysport in the Treatment of Glabellar Lines in Chinese Subjects

Phase 3
Completed
Conditions
Glabellar Lines
Interventions
Drug: Placebo
Biological: Botulinum toxin type A
First Posted Date
2015-05-21
Last Posted Date
2019-08-06
Lead Sponsor
Ipsen
Target Recruit Count
520
Registration Number
NCT02450526
Locations
🇨🇳

West China Hospital, Sichuan University, Chengdu, China

🇨🇳

Chinese PLA General Hospital, Beijing, China

🇨🇳

Peking Union Medical College Hospital, Beijing, China

and more 7 locations

Study to Document the Effectiveness of Dysport in Patients Suffering From Upper Limb Spasticity (ULS) After Stroke

Completed
Conditions
Post Stroke Arm Spasticity
First Posted Date
2015-05-14
Last Posted Date
2018-12-21
Lead Sponsor
Ipsen
Target Recruit Count
108
Registration Number
NCT02444494
Locations
🇵🇱

Indywidualna Praktyka lekarska, Ciecierzyn, Poland

🇵🇱

Samodzielny Publiczny Centralny Szpital Kliniczny im, Śląskiego Uniwersytetu Medycznego w Katowicach Oddział Neurologii Wieku Podeszłego, Katowice, Poland

🇵🇱

Samodzielny Publiczny Zespół Zakładów Opieki Zdrowotnej w Sandomierzu - Szpital - Oddział Neurologii z Pododdziałem Udarowym, Sandomierz, Poland

and more 3 locations

Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly

Phase 1
Completed
Conditions
Acromegaly
Interventions
First Posted Date
2015-03-24
Last Posted Date
2019-04-25
Lead Sponsor
Ipsen
Target Recruit Count
28
Registration Number
NCT02396953
Locations
🇷🇺

Kazan state Medical Academy, Kazan, Russian Federation

🇷🇺

North-Western State Medical University, Saint-Petersburg, Russian Federation

🇫🇷

CHU le BOCAGE, Dijon, France

and more 33 locations

Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment.

Completed
Conditions
Acromegaly
First Posted Date
2015-03-24
Last Posted Date
2018-12-21
Lead Sponsor
Ipsen
Target Recruit Count
152
Registration Number
NCT02396966

Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients

Completed
Conditions
Spasticity
First Posted Date
2015-03-17
Last Posted Date
2017-10-02
Lead Sponsor
Ipsen
Target Recruit Count
239
Registration Number
NCT02390206
Locations
🇧🇷

Hospital Alemão Oswaldo Cruz, São Paulo, Brazil

🇧🇷

Centro Catarinense de Reabilitação, Florianópolis, Brazil

🇧🇷

Hospital Bettina Ferro de Souza Campus IV da Universidade Federal do Pará, Belém, Brazil

and more 8 locations

Botulinum Toxin A Associated Costs in the Treatment of Upper Limb Spasticity Post Stroke

Completed
Conditions
Upper Limb Spasticity Post-Stroke
First Posted Date
2015-03-10
Last Posted Date
2019-01-07
Lead Sponsor
Ipsen
Target Recruit Count
57
Registration Number
NCT02384330
Locations
🇵🇹

Centro de Medicina de Reabilitação de Alcoitão, Alcabideche, Portugal

🇵🇹

C. H. T. M. A. D. - Unidade Hospitalar de Vila Real, Vila Real, Portugal

🇵🇹

C. H. A. - Hospital de Faro, Faro, Portugal

Quality of Life in Patients With Inoperable Malignant Bowel Obstruction

Phase 2
Terminated
Conditions
Intestinal Obstruction
Interventions
First Posted Date
2015-02-19
Last Posted Date
2019-11-22
Lead Sponsor
Ipsen
Target Recruit Count
43
Registration Number
NCT02365584
Locations
🇮🇹

Ospedale Sacro Cuore di Gesù - Fatebenefratelli, Benevento, Italy

🇮🇹

Ospedale San Raffaele IRCCS, Ginecologia oncologica, Milano, Italy

🇮🇹

Ospedali riuniti Ancona- Dipartimento Medicina Interna - Clinica Oncologica, Ancona, Italy

and more 10 locations
© Copyright 2025. All Rights Reserved by MedPath